Search results
Status of Chinese citizen journalist who reported on COVID unknown on day of expected prison release
Seattle Times· 2 days agoThe whereabouts of a Chinese citizen journalist who served four years in prison for reporting on the early days of the pandemic in Wuhan and was expected to be released Monday ...
Baidu's robotaxi unit expects to turn profitable next year
NBC Bay Area· 13 hours agoChinese tech company Baidu said Wednesday its Apollo Go robotaxi arm expects to turn profitable next...
It’s time to quash campus radicalism
The Washington Times· 7 days agoThe sight of kaffiyeh-clad crazies storming the barricades outside the Met Gala, burning an American flag, and vandalizing the 107th Infantry Memorial in...
The Missing Factor In Explanations Of China’s Economic Distress: COVID – Part 2: Estimating The True...
Forbes· 3 days agoChina abandoned its zero-COVID program in December 2022. Travel restrictions were lifted. The...
Traditional Chinese exercises find favor
China Daily· 6 days agoA student at Huazhong Agricultural University in Wuhan, Hubei province, used to consider tai chi and other traditional Chinese exercises to be sports for...
Trump suggests Chinese migrants are in the US to build an 'army.' The migrants tell another story
Associated Press· 2 days agoWhen a potential employer pulled up near the street corner, home to a Chinese bakery and pharmacy,...
Status of Chinese citizen journalist who reported on COVID unknown on day of expected prison release
U-T San Diego· 2 days agoThe whereabouts of a Chinese citizen journalist who served four years in prison for reporting on the early days of the pandemic in Wuhan and was expected to be released Monday ...
House COVID origins panel accuses Fauci adviser of obstructing probe, subpoenas him for public...
New York Post· 7 days agoMorens communicated privately with Daszak to try to reinstate funding for an NIH grant to experiment...
Expert reaction: AstraZeneca withdraws its COVID-19 vaccine
Cosmos· 5 days agoAstraZeneca developed the first vaccine for COVID-19, beating the competition, but this week they’ve...
Opinion | Now is the time to talk about vaccines, but Covid-19 leaves polarising legacy
South China Morning Post· 1 day agoOther drug makers such as BioNTech and Serum Institute have also faced lawsuits in Germany and India...